Acticor Biotech, a key R&D deal after a successful funding round for the treatment in the acute phase of ischemic stroke
March 2017. La Gazette du Laboratoire publishes an article on Acticor Biotech: “Acticor Biotech, a key R&D deal after a successful funding round for the treatment in the acute phase of ischemic stroke.